Brainstorm Cell Therapeutics Inc. BCLI
0.97
0.02
2.11%
as of 25 Sep
- Market cap
- $7.0M
- P/E
- 0.0×
Follow BCLI
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
12.09 | 1.74 | 1.65 | 0.19 | 3.85 | 3.69 | 0.35 | 0.24 | 0.04 | 0.03 |
Net Debt/EBITDA |
2.29 | 1.58 | 0.51 | (0.03) | 1.25 | 0.85 | 0.06 | 0.06 | (0.01) | (0.10) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 19.33% | 5.18% | 4.99% | 16.89% | 0.00% | 16.38% | 94.62% |
Debt/Equity |
0.00 | 0.00 | 0.00 | (0.10) | 0.07 | 0.08 | (0.47) | 0.00 | (0.04) | (0.10) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
1.18 | 0.48 | 0.89 | 0.48 | 1.11 | 1.07 | 0.80 | 1.19 | 0.78 | 0.68 |
Capex/Depreciation |
(0.14) | (2.12) | (3.35) | (2.88) | (1.73) | (1.27) | (0.10) | (0.07) | 0.05 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (41.46%) | (62.76%) | (256.02%) | 645.29% | (273.75%) | (89.25%) | (297.38%) | 436.73% | 184.17% | 116.14% | |
| (35.78%) | (44.63%) | (123.16%) | (261.83%) | (110.09%) | (60.74%) | (128.69%) | (271.62%) | (384.87%) | (722.28%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(50.44%) | (110.73%) | (296.20%) | 174.39% | (96.02%) | (134.73%) | 509.91% | 329.66% | 142.46% | 98.49% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(4.79) | (2.03) | (9.56) | (8.02) | (17.87) | (11.02) | (7.95) | (7.13) | (1.81) | (0.75) |
Cash per Share |
8.03 | 6.19 | 5.30 | 0.39 | 21.06 | 9.16 | 1.23 | 0.45 | 0.04 | 0.00 |
Shareholders Equity per Share |
7.95 | 4.70 | 3.76 | (8.37) | 17.81 | 8.01 | (1.24) | (1.69) | (1.55) | (1.08) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.95 | 4.70 | 3.76 | (8.37) | 17.81 | 8.01 | (1.24) | (1.69) | (1.55) | (1.08) |
Free Cash Flow |
(5.96) | (2.54) | (12.76) | (11.72) | (35.57) | (26.59) | (19.35) | (20.48) | (9.08) | (6.97) |
Working Capital |
9.58 | 4.08 | 4.06 | (14.29) | 32.01 | 16.96 | (5.69) | (5.90) | (8.59) | (10.70) |
Capital Expenditures |
(0.10) | (0.18) | (0.37) | (0.47) | (0.38) | (0.33) | (0.03) | (0.02) | 0.01 | — |
Net Current Asset Value |
9.58 | 4.08 | 4.06 | (15.40) | 27.45 | 13.35 | (8.36) | (7.17) | (9.21) | (10.70) |
| Other line items | ||||||||||
Quick Ratio |
11.92 | 1.52 | 1.46 | 0.17 | 3.76 | 3.51 | 0.35 | 0.17 | 0.03 | 0.01 |
Depreciation/Fixed assets |
2.40 | 0.22 | 0.17 | 0.17 | 0.20 | 0.22 | 0.31 | 0.39 | 0.55 | 0.85 |
Cash ROIC |
(30.94%) | (20.21%) | (107.94%) | 117.48% | (45.36%) | (64.00%) | (1,451.83%) | 594.27% | 130.92% | 80.21% |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(4.71) | (1.89) | (9.29) | (7.70) | (17.68) | (10.88) | (7.93) | (7.12) | (1.81) | (0.75) |
Capex per Share |
(0.08) | (0.14) | (0.28) | (0.32) | (0.19) | (0.14) | (0.01) | (0.01) | 0.00 | 0.00 |
Average Receivables |
0.53 | 0.49 | 1.34 | 2.18 | 1.33 | 0.20 | 0.09 | 0.07 | 0.06 | 0.07 |
Average Payables |
0.76 | 0.88 | 2.99 | 9.61 | 10.05 | 4.56 | 4.96 | 5.59 | 5.52 | 6.57 |
Average Assets |
13.92 | 11.09 | 11.33 | 8.88 | 28.90 | 40.27 | 18.86 | 6.33 | 3.02 | 1.43 |
Average Common Equity |
12.02 | 7.89 | 5.45 | (3.60) | 11.62 | 27.40 | 8.16 | (3.94) | (6.31) | (8.87) |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates